REZUROCK is surely an inhibitor of UGT1A1. Coadministration of REZUROCK having a UGT1A1 substrate decreased plasma concentrations from the glucuronide metabolite, which can boost the threat of adverse reactions linked to delicate substrates of UGT1A1Stems cells are characterised by their capability to differentiate into distinctive cell types even